Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_4534_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Contents
- •1.1.9 Laryngeal Atresia
- •1.1.10 Laryngeal Webs
- •1.1.11 Congenital Subglottic Stenosis
- •1.1.12 Laryngeal Cleft
- •1.1.13 Tracheoesophageal Fistula
- •1.1.14 Tracheal Bronchus
- •1.2.2 Mesenchyme Development
- •1.2.4 Lung Development
- •1.2.4.1 Embryonic Stage
- •1.2.4.2 Pseudoglandular Stage
- •1.1.1 Oral Cavity
- •1.1.2 Nasal Cavity
- •1.1.3 Palate
- •1.1.4 Primitive Pharynx
- •1.1.5 Upper Airway Anomalies
- •1.1.6 Cleft Lip/Palate
- •1.1.7 Choanal Atresia
- •1.1.8 Laryngomalacia
- •1.2.4.3 Canalicular Stage
- •1.2.4.4 Saccular Stage
- •1.2.4.5 Alveolar Stage
- •1.2.5 Congenital Respiratory System Defects
- •1.2.5.1 Tracheal Agenesis
- •1.2.5.2 Congenital Tracheal Stenosis
- •1.2.5.3 Lung Agenesis
- •1.2.5.4 Lung Hypoplasia
- •References
- •2.1 Introduction
- •2.2 Nasal Cavity
- •2.2.1 Vestibule
- •2.2.2 Respiratory Mucosa
- •2.2.3 Olfactory Mucosa
- •Supporting Cells
- •Basal Cell
- •Olfactory Receptor Cell (Bipolar Neuron)
- •Brush Cell (Microvillar Cell)
- •2.2.3.2 The Lamina Propria
- •2.2.3.3 Olfactory Glands (Bowman’s Glands)
- •2.3 Paranasal Sinuses
- •2.4 Pharynx
- •2.5 Larynx
- •2.6 Trachea
- •2.6.1.1 Ciliated Columnar Cells
- •2.6.1.2 Goblet Cells
- •2.6.1.3 Brush Cells
- •2.6.1.4 Basal Cells
- •2.6.1.5 Enteroendocrine System Cells (Kulchitsky Cells or DNES Cells)
- •2.6.2 Lamina Propria
- •2.7 Lungs
- •2.7.1 Pleura
- •2.7.2 Bronchi
- •2.7.3 Bronchioles
- •2.7.3.1 Terminal Bronchioles
- •2.7.3.2 Respiratory Bronchioles
- •2.7.4 Ductus Alveolaris
- •2.7.5 Alveoli
- •2.7.5.2 Type II Alveolar Cell (Septal Cell, Large Alveolar Cell)
- •References
- •3.1.1.3 Nerves
- •Ophthalmic Division
- •Maxillary Division
- •Parasympathetic Nerve Supply
- •3.1.1.4 Bony Anatomy
- •3.1.1.5 Cartilaginous Pyramid
- •3.1.1.6 Structure
- •External Nasal Anatomy
- •Internal Nasal Anatomy
- •3.1.2 Nasal Physiology
- •3.1.2.1 Nasal Airflow
- •3.1.2.2 Abnormal Nasal Physiology
- •3.2.1 Larynx Anatomy
- •Cricoid Cartilage
- •Thyroid Cartilage
- •Epiglottis
- •Arytenoid Cartilages
- •Corniculate Cartilages
- •Cuneiform Cartilages
- •Extrinsic Ligaments
- •Intrinsic Ligaments
- •Laryngeal Cavity
- •Piriform Recesses
- •Cricothyroid Muscles
- •Posterior Cricoarytenoid Muscles
- •Lateral Cricoarytenoid Muscles
- •Transverse Arytenoid Muscle
- •Thyroarytenoid Muscles
- •Superior Laryngeal Nerve
- •Arteries
- •Veins
- •Lymphatics
- •Swallowing
- •Respiration
- •Phonation
- •3.2.2.1 Reflex Glottic Closure
- •References
- •4.1 Introduction
- •4.2.1 Choanal Atresia
- •4.2.2 Pyriform Aperture Stenosis
- •4.2.3 Cleft Lip Nasal Deformity
- •4.2.4 Nasolacrimal Duct Cysts
- •4.2.5 Encephaloceles
- •4.3 Craniofacial Anomalies
- •4.3.1 Pierre Robin Syndrome
- •4.3.2 Treacher-Collins Syndrome
- •4.3.3 Crouzon Syndrome
- •4.3.4 Down Syndrome
- •4.3.5 Apert Syndrome
- •4.4.1 Thyroglossal Duct Cyst
- •4.4.2 Laryngomalacia
- •4.4.3 Vocal Fold Paralysis
- •4.4.5 Subglottic Stenosis
- •4.4.6 Subglottic Hemangioma
- •4.4.7 Laryngeal Cysts
- •4.4.8 Laryngeal Cleft
- •4.5 Conclusion
- •References
- •5.1 Innate Immunity
- •5.2 Adaptive Immunity
- •References
- •6.1 Introduction
- •6.2 Innate Immunity
- •6.3 Adaptive Immunity
- •References
- •7.1 Introduction
- •References
- •8: Respiratory Microbiome
- •8.1 Introduction
- •8.2.1 Childhood Asthma
- •8.2.2 Asthma Exacerbation
- •8.3 Bacteriome
- •8.4 Virome
- •8.5 Mycobiome
- •References
- •9.1 Introduction
- •References
- •10.1 Introduction
- •10.3.3 The Appointment Process, Explained
- •10.3.5 Parental Involvement
- •10.4 Coordinating Care When Your Child Is Ill
- •10.4.3 Exhibit Cohesion
- •10.6 Conclusion
- •References
- •11.1 Introduction
- •11.2 Nasal Cavity
- •11.2.1 Choanal Atresia
- •11.2.2 Rhinosinusitis
- •11.2.4 Juvenile Nasopharyngeal Angiofibroma
- •11.3 Pharynx
- •11.4 Nasopharynx
- •11.4.1 Adenoid Hypertrophy
- •11.4.2 Nasopharyngeal Carcinoma
- •11.5 Oropharynx
- •11.5.1 Thyroglossal Duct Cyst
- •11.6 Hypopharynx
- •11.6.1 Retropharyngeal Abscess
- •11.6.2 Lymphatic Malformation
- •11.6.4 Lymphoma
- •11.6.5 Rhabdomyosarcoma
- •11.7 Larynx
- •11.7.1 Subglottic Stenosis
- •11.7.2 Laryngotracheal Papillomatozis
- •11.7.3 Croup
- •11.7.4 Epiglottitis
- •11.7.5 Foreign Body Aspiration
- •References
- •12.2.1 Plain Radiography
- •12.2.1.1 The Thymus
- •Tracheal Buckling
- •Hilum
- •Diaphragm
- •Mediastinal Borders
- •Lung Opacities
- •Cystic Lung Diseases
- •Pulmonary İnterstitial Emphysema (PIE)
- •Unilateral Hyperlucent Lung
- •12.2.2 Fluoroscopy
- •12.2.3 Ultrasound
- •12.2.4 Computed Tomography
- •12.2.5 Magnetic Resonance Imaging (MRI)
- •12.2.6 Angiography
- •12.2.7 Positron Emission Tomography (PET)
- •12.3 Conclusion
- •References
- •13.1 Introduction
- •13.2 Nasal Diagnostic Procedures
- •13.2.1 Indications
- •13.2.2 Contraindications
- •13.2.3 Anatomical Features
- •13.2.4 Technical Considerations
- •13.2.5 Technique
- •13.2.5.1 First Pass
- •13.2.5.2 Second Pass
- •13.2.5.3 Third Pass
- •13.3 Flexible Laryngoscopy
- •13.4 Direct Laryngoscopy
- •13.5 Video Laryngoscopy
- •13.5.1 Indications
- •13.5.2 Contraindications
- •13.5.3 Outcomes
- •13.5.4 Equipment
- •13.5.5 Approach Considerations
- •References
- •14.1 Upper Airways
- •14.2.3 Laryngeal Pathologıes
- •References
- •15.1 Introduction
- •15.2 Airway Measurements
- •References
- •16.1 Introduction
- •16.2 Background
- •References
- •17: Allergen Testing: Purpose, Procedure, Interpretation
- •17.1 Introduction
- •17.2 Tests
- •17.2.1 Skin Tests
- •17.2.3 Component Resolved Diagnosis (CRD)
- •17.2.4 Tryptase
- •17.2.5 Basophil Activation Test (BAT)
- •17.2.6 Provocation Tests
- •17.2.7 Nasal sIgE
- •17.2.8 Nasal Smear Eosinophilia
- •17.2.9 Eosinophilic Cationic Protein (ECP)
- •References
- •18: Smell Testing: Purpose, Procedure, Interpretation
- •18.1 Introduction
- •18.2 Possible Olfactory Disorder Diagnosis
- •18.2.1 Conductive Defects
- •18.2.3 Inherited Disorders
- •18.2.3.1 Hormonal Disturbances
- •18.4 Odor Threshold Tests
- •18.8.1 Butanol Threshold Test
- •18.8.1.1 The Penn State University Odor Identification Exam
- •18.8.2 Cross-Cultural Smell Identification Test
- •18.8.3 Sniffin’ Sticks
- •References
- •19: Taste Testing: Purpose, Procedure, Interpretation
- •19.1 Introduction
- •19.2 Definitions
- •19.2.1 Taste Dysfunction Abnormalities
- •19.4.1 Taste Dysfunction
- •19.4.2 COVID-19
- •19.5 Taste Disorder Diagnosis
- •19.6.2 Magnitude Matching
- •19.6.3 Spatial Test
- •References
- •20.1 Introduction
- •20.2 Primary Otalgia Causes
- •20.2.1 Auricle
- •20.2.1.1 Infections
- •20.2.1.2 Trauma
- •20.2.1.3 Allergic Angioedema
- •20.2.1.4 Thermal Damage
- •20.2.2 External Auditory Canal
- •20.2.2.1 Otitis Externa
- •20.2.2.2 Malignant Otitis Externa
- •20.2.2.3 Eczematous Dermatitis
- •20.2.2.4 Furunculosis
- •20.2.2.5 Foreign Body
- •20.2.2.6 Cerumen Impaction
- •20.2.2.7 Tumors
- •20.2.3 Middle Ear
- •20.2.3.1 Acute Otitis Media
- •20.2.3.3 Eustachian Tube Dysfunction
- •20.2.3.4 Cholesteatoma
- •20.2.3.5 Trauma
- •20.3 Secondary Otalgia Causes
- •20.3.1 Oropharyngeal Infections
- •20.3.2 Dental Causes
- •20.3.3 Auricular Lymphadenitis
- •20.3.4 Neck Abscess
- •20.3.5 Parotitis
- •20.3.6 Temporomandibular Joint Dysfunction
- •20.3.7 Sinusitis
- •20.4 Differential Diagnosis
- •References
- •21.1 Introduction
- •21.2 Bacterial Otitis Externa
- •21.3 Acute Otitis Media
- •21.4 Chronic Suppurative Otitis Media
- •21.5 Foreign Body
- •21.5.1 Cerumen
- •21.5.2 Tympanostomy Tube Drainage
- •21.5.3 Traumatic Cerebrospinal Fluid Otorrhea
- •21.5.5 Necrotizing Otitis Externa (Malignant External Otitis)
- •21.5.6 Neoplasms
- •21.5.7 Polyps
- •21.5.8 Otomycosis
- •21.5.9 First Branchial Cleft Cysts
- •21.5.10 Cholesteatoma
- •21.5.11 Spontaneous Cerebral Spinal Fluid Otorrhea
- •References
- •22.1 Introduction
- •22.4 Congenital Causes
- •22.4.1 Choanal Atresia
- •22.4.2 Pyriform Apertura Stenosis
- •22.4.3 Nasal Midline Congenital Masses
- •22.4.3.1 Nasal Dermoid Cyst
- •22.4.3.2 Nasal Glioma
- •22.4.3.3 Encephalocele (Encephalo-Meningocele)
- •Differential Diagnosis
- •22.4.3.4 Nasolacrimal Duct Cyst (Dacryocystocele)
- •22.5 Infectious Causes
- •22.5.1.1 Rhinitis Etiology
- •22.5.2 Neonatal Rhinitis
- •22.5.3 Bacterial or Viral Rhinitis
- •22.5.4 Iatrogenic Rhinitis
- •22.5.5 Infectious Rhinitis (Rhinosinusitis)
- •22.6 Adenoid Hypertrophy
- •22.7 Inflammatory Causes
- •22.7.1 Allergic Rhinitis
- •22.7.2 Nonallergic Rhinitis
- •22.7.3 Eosinophilic Nonallergic Rhinitis (NARES)
- •22.7.4 Nasal Polyp
- •22.7.5 Antrochoanal Polyp
- •22.7.6 Inferior Turbinate Hypertrophy
- •22.8 Neoplasia
- •22.8.1 Benign Tumors (Juvenile Nasopharyngeal Angiofibroma)
- •22.8.2 Malignant Tumors
- •22.9 Systemic Causes
- •22.9.1 Cystic Fibrosis
- •22.9.2 Primary Ciliary Dyskinesia
- •22.10 Trauma/Iatrogenic Causes
- •22.10.1 Nasal Trauma-Septal Hematoma
- •22.10.2 Septum Deviation
- •22.10.3 Nasal Foreign Bodies
- •References
- •23.1 Introduction
- •23.2 Pathophysiology
- •23.3 Allergic Rhinitis
- •23.4 Non-allergic Rhinitis
- •23.5 Infectious Rhinitis
- •23.6.1 Vasomotor Rhinitis
- •23.7 Evaluation
- •23.8 Diagnosis
- •23.9 Treatment
- •23.10 Prognosis
- •23.11 Conclusion
- •References
- •24.1 Introduction
- •24.2 Pathogenesis
- •24.3 Diagnosis
- •24.3.1 History
- •24.3.2 Examination
- •24.4 Differential Diagnoses
- •24.5 CSF Rhinorrhea
- •24.5.1 CSF Physiology
- •24.5.1.1 Pathogenesis
- •24.6 Diagnosis
- •24.6.1 Chemical Diagnosis
- •24.6.2 Imaging Diagnosis
- •24.7 Treatment
- •24.7.1 Surgical Technique
- •References
- •25.1 Introduction
- •25.1.1 Waldeyer Ring
- •25.3 Anatomy
- •25.3.1 Lymphatic Drainage
- •25.3.1.1 Nerve Supply
- •25.6 Tonsillary Hypertrophy
- •25.7 Physical Examination
- •25.8.1 Obstructive Sleep Apnea
- •References
- •26.1 Introduction
- •26.5 Halitosis Physiopathology
- •26.6.1 Oral Halitosis (Intraoral Halitosis, Oral Malodor)
- •26.6.1.1 Periodontal Infections
- •26.6.1.2 Tongue Oriented Halitosis
- •26.6.1.3 Peritonsillar Abscess
- •26.7 Paranasal Sinus Diseases
- •26.8 Adenoid Vegetation
- •26.9 Chronic Pharyngitis
- •26.10 Chronic Tonsillitis
- •26.11 Tonsillolith
- •26.12 Non-Oral Halitosis
- •26.13 Gastroesophageal Reflux
- •26.14 Diagnosis
- •26.14.1 Organoleptic Measurement
- •26.14.2 Sulfur Monitoring
- •26.14.2.1 Indirect Methods
- •26.14.2.3 Ammonia Monitoring
- •26.14.2.4 Polymerase Chain Reaction (PCR)
- •26.15 Physical Examination
- •References
- •27.1 Introduction
- •27.2 Epidemiology
- •27.4 Diagnosis
- •27.5.1 Clinical Assessment
- •27.6 Treatment
- •27.6.1 Voice Therapy
- •27.7 Phonosurgery
- •References
- •28.1 Introduction
- •28.2 Epidemiologic Characteristics
- •28.3 Swallowing Physiologic Phases
- •28.3.1.1 Prematurity
- •28.3.1.2 Neuromuscular
- •28.3.1.5 Cardiopulmonary Disease
- •28.4 Symptoms
- •28.5 Clinical Feeding Assessment
- •28.7 Flexible Endoscopic Swallowing Evaluation
- •28.8 Imaging
- •28.9 Endoscopic Assessments
- •28.9.1 High-Resolution Manometry
- •28.10 Medical Management
- •28.11 Surgical Management
- •28.11.1 Ankyloglossia
- •28.11.2 Laryngomalacia
- •28.11.3 Laryngeal Cleft
- •28.12 Conclusions
- •References
- •29.1 Introduction
- •29.2 Reactive Lymph Node Enlargements
- •29.3 Vaccines
- •29.4 Acute Suppurative Lymphadenitis
- •29.6 Granulomatous Lymphadenitis
- •29.6.1 Mycobacterial Infection
- •29.6.2 BCG Vaccine
- •29.6.3 Cat-Scratch Disease
- •29.6.4 Sarcoidosis
- •29.6.5 Kikuchi-Fujimoto Disease
- •29.7 Malignancies
- •29.8 Diagnosis
- •References
- •30.1 Introduction
- •30.2 Upper Airway Cough Syndrome
- •30.3 Chronic Rhinosinusitis
- •30.5 Otogenic Cough
- •30.6 Laryngeal Clefts
- •30.7 Conclusion
- •References
- •31.1 Introduction
- •31.5.1 Vocal Cord Disfunction (VCD)
- •31.5.2 Obstructive Sleep Apnea Syndrome (OSAS)
- •31.5.3 Allergic or Non-Allergic Rhinitis
- •31.6 Conclusion
- •References
- •32.1 Introduction
- •32.2.1 Non-massive Hemoptysis
- •32.2.2 Massive Hemoptysis
- •32.4 Diagnostic Evaluation
- •32.4.1 History
- •32.4.1.1 Infection Warning Signs
- •32.4.1.2 Choking
- •32.4.1.3 Exposures
- •32.4.1.4 Underlying Medical Problems
- •32.4.2 Physical Examination
- •32.4.3 Laboratory Evaluation
- •32.4.4 Imaging
- •32.5.1 Respiratory Illness
- •32.5.3 Trauma
- •32.5.4 Hemoptysis Mimics
- •References
- •33.1 Introduction
- •33.6 Conclusion
- •References
- •34: Pediatric Allergic Rhinitis: Otolaryngology Perspective
- •34.1 Introduction
- •34.2 Epidemiology
- •34.2.1 Prevalence
- •34.2.2 Risk factors
- •34.3.1 Classical Pathway
- •34.3.2 Nasal Pathway
- •34.4.2 Physical Examination
- •34.4.3 Diagnostic Tests
- •34.4.4 Nasal Cytology
- •34.4.5 Imaging
- •34.5.1 Adenoid Hypertrophy
- •34.5.2 Nasal Septal Deviation
- •34.5.3 Chronic Rhinosinusitis
- •34.5.4 Turbinate Hypertrophy
- •34.5.5 Nasal Foreign Body
- •34.5.6 Other Clinical Conditions
- •34.6.1 Saline Irrigation (Douching)
- •34.7 Treatment
- •34.7.1 Oral Antihistamines
- •34.7.2 Intranasal Steroids
- •34.7.3 Leukotriene Inhibitors
- •34.7.5 Oral Steroids
- •34.7.6 Intranasal Antihistamines
- •34.7.7 Immunotherapy (Sublingual-Subcutaneous)
- •34.8 Conclusion
- •References
- •35: Allergic Rhinitis: Pediatric Pulmonologist Perspective
- •35.1 Introduction
- •35.2.1 Epidemiological Relationship
- •35.2.4 Immunopathology
- •35.2.7 Non-pharmaceutical Treatment Method
- •35.2.8 Pharmaceutical Medication Policy
- •35.2.9 Immunotherapy Against Allergens
- •35.6 Conclusion
- •References
- •References
- •37.1 Introduction
- •37.2 Adenoid Hypertrophy
- •37.7 Preoperative Evaluation
- •37.8 Contraindications
- •37.9 Complications
- •37.9.1 Bleeding
- •37.9.2 Hypernasality
- •37.9.3 Surgical Traumas
- •37.9.4 Torticollis
- •37.9.5 Otitis Media
- •37.9.6 Psychological Trauma
- •37.9.7 Nasopharyngeal Stenosis
- •37.9.8 Recurrence
- •37.10 Postoperative Care
- •37.11 Surgery
- •37.12.1 Adenoiditis
- •References
- •38.1 Introduction
- •38.2 Anatomy
- •38.2.1 Palatine Tonsils (Faucial Tonsils)
- •38.2.2 Lingual Tonsil
- •38.2.3 Adenoids (Pharyngeal Tonsil)
- •38.2.4 Tubal Tonsils
- •38.5.1 Viral Tonsillitis
- •38.5.2 Bacterial Tonsillitis
- •38.5.3 Candida
- •38.6.1 Suppurative Complications
- •38.6.1.1 Peritonsillar Abscess (Quincy Tonsil)
- •Lemierre’s Syndrome
- •38.6.2 Nonsuppurative Complications
- •38.6.2.1 Acute Rheumatic Fever
- •38.6.2.2 Poststreptococcal Glomerulonephritis
- •38.6.2.3 Scarlet Fever
- •38.6.2.6 Palmoplantar Pustulosis (PPP)
- •38.6.2.7 IgA Nephropathy
- •38.7 Clinical Manifestation
- •38.7.1 Infection
- •38.7.2 Obstruction
- •38.7.3 Neoplasia
- •38.8 Diagnosis
- •38.8.2 Physical Examination
- •38.8.3 Laboratory
- •38.8.4 Imagining
- •38.8.5 Polysomnography
- •38.9 Treatments
- •38.9.1 Medical Treatment
- •38.9.2 Surgery
- •38.9.2.2 Tonsillectomy
- •38.9.3.1 Intraoperative Complications
- •38.9.3.4 Postoperative Long-Term Complications (>weeks)

482
Fig. 37.1 Endoscopic
image of adenoids
Ç. F. Koca et al.
the removal of peritubaric and perichoanal adenoidal tissues can be achieved, and
the boundaries and depth of the resection can be controlled [35] (Fig.37.1).
37.12 Adenoids andRelated Diseases
37.12.1 Adenoiditis
Adenoiditis can be described as the inammation of the adenoidal tissue due to
infections, allergies, or stomach acid irritation. Adenoiditis is often not alone and is
found as part of more complicated clinical situations, including adenotonsillitis,
pharyngitis, rhinosinusitis, and laryngopharyngeal reux [36].
Purulent, runny nose, postnasal discharge, fever, and cough should suggest the
diagnosis of adenoiditis. Cervical lymphadenopathy, sinusitis, and otitis media can
also accompany adenoiditis. Over four repetitions of this clinical situation annually
can be dened as recurrent adenoiditis [4, 37]. If these symptoms persist despite the
appropriate treatment without any improvement, this clinical situation is called
chronic adenoiditis [4]. Numerous microorganisms may cause inammation in the
adenoidal tissue. Upper-respiratory tract infections due to viral agents frequently
initiate the adenoiditis process and facilitate bacterial infections and proliferation in
the adenoidal tissue. Haemophilus inuenza, Streptococcus pyogenes, Streptococcus
pneumonia, and Staphylococcus aureus are the most frequent bacterial agents
detected from adenoid tissue [38]. Chronic irritation due to gastroesophageal reux
may be a factor in adenoiditis and enlargement of adenoid tissue, especially in
infants and pediatric patients [39]. The precise incidence and prevalence ratio for
adenoiditis remains unclear. If there is only a viral upper-respiratory tract infection,
the doctor can follow up without antibiotics, as many viral infections are selflimiting and improve within 5–7days. If complaints persist or a bacterial infection

37 Meeting Organ forENT andPediatric Pulmonology: Adenoids
483
is considered, the rst-step treatment is appropriate antibiotics. Amoxicillin is the
rst choice. Cefdinir or cefuroxime may be a second alternative if there is insufcient response to amoxicillin treatment. In the case of penicillin allergy, azithromycin or clarithromycin may be alternative agents. The treatment period should be
10 days to suppress relapse rates and antibiotic resistance [36]. Amoxicillinclavunate combination is a good alternative for treating beta-lactamase-forming
agents [40]. Nasal steroid sprays, oral steroids, and oral antihistamines create the
treatment for adenoiditis that occurs due to allergic conditions. Reux treatment
should be given if adenoiditis is considered to develop due to reux [39]. Differential
diagnosis should be made in adenoiditis with sinusitis, rhinosinusitis, pharyngitis,
tonsillitis, nasal polyposis, seasonal allergies, and laryngopharyngeal reux [36].
Adenoidectomy is recommended for recurrent or chronic adenoiditis that persists despite appropriate antimicrobial treatments [6, 41].
37.12.2 Adenoids andEar Diseases
The nasopharynx creates the most superior part of the pharynx, restricted by the
skull base superiorly, by the soft palate inferiorly, by the nasal cavity anteriorly, by
posterior pharyngeal wall posteriorly, the medial pterygoid plates and superior pharyngeal constrictor muscle laterally. The nasopharynx creates a connection between
the nasal cavity and the oropharynx. Eustachian tube (ET) orices and adenoidal
tissue exist in the nasopharyngeal region [42–44]. The relationship between adenoids and ET dysfunctions has been the issue of many studies in the literature.
Different studies have determined that the adenoids contain excessively more mast
cells in cases with ET impairments and otitis media (OM) with effusion [45].
Bacteria creating biolm have been obtained from adenoidal tissues of pediatric
patients with repetitive acute OM and resistant OM with ow. The more common
localization of bacterial biolms is around the ET ostium, which shows that adenoid
tissue is a reservoir for bacteria and adenoiditis and can lead to otitis, rhinosinusitis,
or similar upper-respiratory infections.
Additionally, adenoid hypertrophy can obstruct the ET mechanically, and this
mechanical blockage leads to more difcult middle ear diseases [35]. Adenoid
hypertrophy may block the nasopharyngeal space and occlude the ET.This blockage disrupts the ventilation of the middle ear and the mastoid system [46].
Adenoidectomy may provide recovery in children with recurrent otitis media but is
not suggested as a rst-step treatment unless recommended for upper-airway
obstruction [47].
37.12.3 Adenoids andRhinosinusitis
Chronic rhinosinusitis (CRS) can be described as nasal inammation, and the paranasal sinuses presented by two or more symptoms for at least 12weeks without cessation including nasal blockage, nasal congestion or discharge, facial pain or pressure,

484
Ç. F. Koca et al.
and cough [48, 49]. The diagnosis depends on an endoscopic examination and computed tomography (CT) scan. Although CRS is a frequent disease, the denite incidence in children is unknown [49]. Nasal congestion, cough, rhinorrhea, and
postnasal drip create the most frequent symptoms of CRS [50, 51]. Tatli etal. reported
that 66% of children with chronic cough symptoms had CT scan pathologies in the
paranasal sinuses [52]. The diagnosis of CRS in pediatrics is difcult due to the similar symptomatology to viral upper-respiratory tract infections, adenoiditis/adenoid
hypertrophy and allergic rhinitis. At this point of distinction, families may not always
be able to give a clear anamnesis, and it is difcult to perform an endoscopy on a
young child [49]. The adenoid tissue is closely associated with the paranasal sinuses.
Adenoidectomy is sufcient in treating complaints in some children with CRS [49].
According to the analysis of a study in the literature, it was considered that enlarged
adenoids have similar bacteriology with the middle meatus of children with chronic
or recurrent sinusitis [53]. In children with severe sinusitis reected on radiological
imaging, it has been shown that there is a direct correlation between the incidence of
bacterial isolation from the adenoid tissue and the size of the adenoids [54, 55]. This
result suggests that adenoiditis may cause nasal discharge, and the effect of the adenoids on CRS may be related to their bacterial reservoir rather than their size [49].
The diagnosis of CRS in pediatrics is based on clinical symptoms. Although physical
examination and clinical history are helpful in diagnosis, they cannot distinguish
CRS from adenoiditis, especially in smaller pediatrics. Paranasal CT is the most
frequently used radiological modality in diagnosing CRS. Direct radiography is
more diagnostic than CT. Adenoidectomy, combined with a maxillary sinus wash
procedure following functional endoscopic sinus surgery, is the most preferred surgical procedure in CRS cases that have no improvement despite optimal medical therapy [49]. Ramadan and Tiu reported that children smaller than 7years of age with
asthma had a lower improvement rate and required additional endoscopic sinus surgery procedures [56]. Maxillary antral irrigation is commonly carried out in addition
to adenoidectomy. Ramada etal. reported 60 pediatrics who experienced adenoidectomy due to CRS and observed that children who experienced adenoidectomy solely
had a 61% success range at 12months. On the other hand, patients who had adenoidectomy combined with a sinus wash had an 88% success ratio [57]. Paranasal sinus
CT scan studies showed that 18–45% of children with CRS have radiographic
pathologies [58, 59]. The Lund-Mackay scoring system was described to determine
CRS-dependent CT ndings. A study showed a mean Lund-Mackay score of 2.8in
a pediatric group without complaints of rhinosinusitis. Lund-Mackay scores of 2 or
fewer create a perfect negative predictive value. On the other hand, scores of 5 or
bigger have an ideal positive predictive value for CRS [49, 60, 61] (Fig.37.2).
37.12.4 Adenoids andAllergic Rhinitis
Adenoids are members of upper-respiratory tract-associated lymphoid tissues and
create the organism’s rst step of immune protective barrier and are critical structures in both mucosal and systemic adaptive immunity mechanisms. They play

37 Meeting Organ forENT andPediatric Pulmonology: Adenoids
Fig. 37.2 Lateral
radiographic image of
adenoid tissue
485
crucial functions in mediating local and regional immune mechanisms, as they meet
antigens [35]. Various factors may cause adenoid hypertrophy, but it is frequently
suggested that passive smoking and allergic diseases induce repetitive respiratory
inammation in children via decreased IFN-gamma-generating CD8+ T lymphocytes. Additionally, adenoid tissue is an essential location of allergic inammation
due to the production of total and specic IgEs by adenoid mast cells [62].
Adenoids are formed by lymphoepithelial tissue and consist of lymphocytes, epithelial cells, macrophages, and dendritic cells. The localization and rule of effector T
cells is critical for maintaining an efcient immune reaction. In particular, CD8+ T
lymphocytes may be used in two main ways: cytolysis and synthesis of chemokines,
cytokines, and microbicidal particles. When the synthesis of IFN-gamma by Th1
adenoidal lymphocytes is decreased, patients become more vulnerable to infectious
viral diseases, facilitating the proliferation of pathogenic bacteria in adenoids [63].
Secretory IgA is the primary antibody in adenoids and plays a critical role in mucosal
immunity, connecting to bacteria and preventing bacterial replication in the epithelium. According to the results of some studies, it was reported that IgA synthesis is
seriously lower than in the adenoidal tissue of children diagnosed with OM with
effusion [64]. Toll-like receptors (TLRs) mediate the active relation between innate
and adaptive immunity mechanisms and mechanical factors, including ciliary movement. Recurrent respiratory infections and exposure to cigarette smoke may decrease
the number of TLRs [65]. The over-expression of TLR7in pediatrics with OM with
effusion may indicate the signicant task of these proteins in the immunological and
antimicrobial reaction [66]. De Amici etal. analyzed the potential effects of various
serum mediators that may be indicators of adenoidal hypertrophy in pediatrics.
Primarily, increased serum levels of myeloperoxidase, which is an indicator of neutrophil activation, is determined in pediatrics with repetitive lower respiratory disease; high serum levels of eosinophilic cationic protein, a classical indicator of

486
Ç. F. Koca et al.
eosinophil over functions, are observed in children with repetitive upper-respiratory
diseases; an increased levels of CD163 glycoprotein, a characteristic indicator of
monocyte/macrophage activation, may demonstrate the enlargement of adenoidal
hypertrophy [67]. These negative results may devastate the protective structures of
the nose, facilitating the development of resistant adenotonsillar and respiratory diseases, including pharyngitis, rhinitis, otitis, laryngitis, sinusitis, pneumonia bronchitis, and allergic conditions. The relationship between adenoidal diseases and allergy
is still unclear. Some papers in the literature declared a potential location of allergic
pediatrics, as detected by myriad brightly uorescent IgE mast cells, by the local
production of total and specic IgE, and by the evident eosinophilic inammatory
process, classical in atopic cases. IgA receptors’ synthesis on eosinophils is high in
allergic cases, and infected adenoid tissue may have a different cell content from
healthy adenoids. Although allergic rhinitis is accepted as an important predisposing
factor for adenoid hypertrophy, it is infrequent in the ages when the frequency of
adenoid hypertrophy is high. The clinical complaints of both diseases are similar.
Possibly, only one of the diseases can be diagnosed. Allergic rhinitis and hypertrophied adenoids may cause nasal obstructive symptoms [35]. Ameli etal. reported
that large-sized adenoid tissue can be related to the absence of allergic conditions,
whereas large turbinates may have a relationship with small adenoidal tissue [68]. In
pediatrics with allergic rhinitis associated with hypersensitivity to dust mites, adenoid hypertrophy develops excessively more frequently than in children with other
allergic problems (asthma/atopic dermatitis) or no allergies. Meeting a sensitizing
agent may be the leading cause of adenoidal hypertrophy in pediatrics with allergic
rhinitis, and an appropriate treatment for allergic rhinitis could decrease the ratio of
adenoid hypertrophy in atopic children [35]. A relationship has been found between
childhood exposure to cigarette smoke and many childhood respiratory diseases.
IFN-gamma synthesis by CD8+ T cells is inaccurate in these pediatric patients, creating susceptibility to recurrent respiratory infections [69]. Passive cigarette smoking
elevates the level of proinammatory molecules, decreases the Th1/Th2 ratio, and
activates numerous structural changes in the respiratory nasal mucosa that effect
negatively its ciliary functions [70]. Cytotoxic effects may occur due to the high
concentration of nitric oxide. Smoking activates the production of heat shock proteins. These proteins are produced in tissues as a response to stressor factors. Smoking
achieves its destructive effects in adenoid tissue via reagent oxygen and nitrogen
products. Heat shock protein 70 has been accused of adenoidal hypertrophy in pediatrics exposed to smoking [71]. Koca etal. detected an increased smoking ratio in
parents of children with adenoids compared with the control group [10].
37.12.5 Adenoids andAsthma
Di Matiro etal. reported that enlarged adenoids may affect expiratory nasal ow
[72]. Obturation can be described as decreased airow in the respiratory tract. This
entity causes a reduction of maximum ow values and air volumes in the unit of time
during forced expiration in proportion to vital capacity. Obturation is a decline in the

37 Meeting Organ forENT andPediatric Pulmonology: Adenoids
487
Tiffaneau index (FEV1%/VC). This index is an essential marker of obturation.
Niedzielska etal. found an improvement in the Tiffaneau index in their patients after
adenoidectomy (VC: vital capacity) (FEV1: Forced expiratory volume during the
rst second of expiration) [73]. Madrzynski and Zawisza analyzed the incidence of
adenoidal hypertrophy in pediatrics with allergic rhinitis, and they pointed out that
allergic situations such as allergic rhinitis, atopic dermatitis, and bronchial asthma
enhanced the adenoidal tissue enlargement risk [74]. Kavukcu etal. suggested the
evaluation of spirometric results for adenoid surgery. They observed the improvement of airway obstruction problems in their patients after the adenoid procedure.
According to the study results, the authors declared that PEF, FVC, FEV1/PEF, and
FEV1/FVC values recovered after adenoidectomy [75]. Aykan etal. suggested that
pulmonary function tests may determine patients with mild degrees of adenoid
hypertrophy to assess whether they are candidates for surgery (FEV1: Forced expiratory volume during the rst second of expiration, PVC: forced vital capacity) [76].
Additionally, adenoid hypertrophy has been observed in cases with allergic rhinitis and asthma. According to one study, 52% of patients with only adenoid hypertrophy had signs of lower respiratory tract obstruction detected in pulmonary
function tests [77].
References
1. Duan H, Xia L, He W, etal. Accuracy of lateral cephalogram for diagnosis of adenoid hypertrophy and posterior upper-airway obstruction: a meta-analysis. Int J Pediatr Otorhinolaryngol.
2019;119:1–9.
2. Stamm AC, Pignatari SSN, Balsalobre L.Chapter 175. Transnasal endoscopic-assisted surgery
of the anterior skull base. In: Flint PW, Haughey BH, Lund V, etal., editors. Cummings otolaryngology: head & neck surgery. 6th ed. Philadelphia: Elsevier Saunders; 2015.
3. Casselbrant ML.What is wrong in chronic adenoiditis/tonsillitis anatomical considerations.
Int J Pediatr Otorhinolaryngol. 1999;49:133–5.
4. Kara CO.Chapter 6. Tonsil-adenoid and pharynx infections. In: Koc C, editor. Ear nose throat
diseases and head and neck surgery. 2nd ed. Ankara: Guneş Medicine Bookstores; 2013.
5. Guilleminault C, Stoohs R.Chronic snoring and obstructive sleep apnea syndrome in children.
Lung. 1990;168(Suppl):912–9.
6. Wine TM, Yellon RF.Chapter 71. Infectious and inammatory disease of the oral cavity, oropharynx, and nasopharynx. In: Wackym PA, Snow JB, editors. Ballenger’s otorhinolaryngology head and neck surgery. 18th ed. Shelton: People’s Medical Publishing House; 2016.
7. Arsalah R, Waheed H, Fatima J.Cephalometric assessment of patients with adenoidal faces. J
Pak Med Assoc. 2009;59:747–52.
8. Peltomaki T. The effect of mode of breathing on craniofacial growth. Eur J Orthod.
2007;29:426–9.
9. Mizrahi E.A review of anterior open bite. Br J Orthod. 1978;5:21–7.
10. Koca CF, Erdem T, Bayındır T.The effect of adenoid hypertrophy on maxillofacial development: an objective photographic analysis. J Otolaryngol Head Neck Surg. 2016;45(1):48.
11. Goldstein NA.Chapter 184. Evaluation and management of pediatric obstructive sleep apnea.
In: Flint PW, Haughey BH, Lund V, etal., editors. Cummings otolaryngology: head & neck
surgery. 6th ed. Philadelphia: Elsevier Saunders; 2015.
12. Gottlieb DJ, Chase C, Vezina RM, Heeren TC, Corwin MJ, Auerbcah SH, etal. Sleep- disordered breathing symptoms are associated with poorer cognitive function in 5-year-old children. J Pediatr. 2004;145:458–64.

488
13. Rhodes SK, Shimoda KC, Wald LR, O’Neil PM, Oexmann MJ, Collop NA.Neurocognitive
decits in morbidly obese children with obstructive sleep apnea. J Pediatr. 1995;127:741–4.
14. Kumari S, Bagla J, Singla A.Pediatric obstructive sleep apnea: a review of approach to management. Indian Sleep Med. 2019;14(2):32–7.
15. Joshua B, Bahar G, Sulkes J, etal. Adenoidectomy: long-term follow-up. Otolaryngol Head
Neck Surg. 2006;135:576–80.
16. Ishman SL, Kimple AJ.Chapter 72. Pediatric sleep disordered breathing. In: Wackym PA,
Snow JB, editors. Ballenger’s otorhinolaryngology head and neck surgery. 18th ed. Shelton:
People’s Medical Publishing House; 2016.
17. King EF, Couch ME.Chapter 4. History, physical examination, and the preoperative evaluation. In: Flint PW, Haughey BH, Lund V, etal., editors. Cummings otolaryngology: head &
neck surgery. 6th ed. Philadelphia: Elsevier Saunders; 2015.
18. Cassano P, Gelardi M, Cassano M, Fiorella ML, Fiorella R.Adenoid tissue rhinopharyngeal
obstruction grading based on berendoscopic ndings: a novel approach to therapeutic management. Int J Pediatr Otorhinolaryngol. 2003;67:1303–9.
19. Chien CY, Chen AM, Hwang CF, Su CY.The clinical signicance of adenoid-choanae area
ratio in children with adenoid hypertrophy. Int J Pediatr Otorhinolaryngol. 2005;69:235–9.
20. Josephson GD, Duckworth L, Hossain J. Proposed denitive grading system tool for the
assessment of adenoid hyperplasia. Laryngoscope. 2011;121:187–93.
21. Parikh SR, Coronel M, Lee JJ, Brown SM.Validation of a new grading system for endoscopic
examination of adenoid hypertrophy. Otolaryngol Head Neck Surg. 2006;135:684–7.
22. Paradise JL, Bernard BS, Colborn DK, Janosky JE.Assessment of adenoidal obstruction in
children: clinical signs versus roentgenographic ndings. Pediatrics. 1998;101:979–86.
23. Cho JH, Lee DH, Lee NS, Won YS, Yoon HR, Suh BD.Size assessment of adenoid and nasopharyngeal airway by acoustic rhinometry in children. J Laryngol Otol. 1999;113:899–905.
24. Schupper AJ, Nation J, Pransky S.Adenoidectomy in children: what is the evidence and what
is its role? Curr Otorhinolaryngol Rep. 2018;6(1):64–73.
25. Fortier MA, Del Rosario AM, Rosenbauın A, Kain ZN.Beyond pain: predictors of postoperative maladaptive behavior change in children. Paediatr Anaesth. 2010;20:445–53.
26. Koç C, Kocaman F, Aygenç E, Özdem C, Çekiç A.The use of preoperative lidocaine to prevent stridor and laryngospasm after tonsillectoıny and adenoidectomy. Otolaryngol Head Neck
Surg. 1998;118:880–2.
27. Simonsen AR, Duncavage A, Becker SS.A review of malpractice cases after tonsillectomy
and adenoidectomy. Int J Pediatr Otorhinolaryngol. 2010;74:977–9.
28. Pagella F, Matti E, Colombo A, Giourgos G, Mira E. How we do it: a combined method
of traditional curette and power-assisted endoscopic adenoidectomy. Acta Otolaryngol.
1996;129:556–9.
29. Buchinsky FJ, Lowry MA, Isaacson G.Do adenoids regrow after excision? Otolaryngol Head
Neck Surg. 2000;123:576–81.
30. Stanislaw P Jr, Koltai PJ, Feustel PJ.Comparison of powerassisted adenoidectomy vs adenoid
curette adenoidectomy. Arch Otolaryngol Head Neck Surg. 2000;126:845–9.
31. Elluru RG, Johnson L, Myer CM.Electrocautery adenoidectomy compared with curettage and
power-assisted methods. Laryngoscope. 2002;112:23–5.
32. Havas T, Lowinger D.Obstructive adenoid tissue: an indication for powered-shaver adenoidectomy. Arch Otolaryngol Head Neck Surg. 2002;128:789–91.
33. Murray N, Fitzpatrick P, Guarisco JL.Powered partial adenoidectomy. Arch Otolaryngol Head
Neck Surg. 2002;128:792–6.
34. Ezzat WF. Role of endoscopic nasal examination in reduction of nasopharyngeal adenoid
recurrence rates. Int J Pediatr Otorhinolaryngol. 2010;74:404–6.
35. Brambilla I, Pusateri A, Pagella F, Caimmi D, Caimmi S, Licari A, etal. Adenoids in children:
advances in immunology, diagnosis, and surgery. Clin Anat. 2014;27(3):346–52.
36. Bowers I, Shermetaro C. Adenoiditis. In: StatPearls [Internet]. Treasure Island: StatPearls
Publishing; 2021.
Ç. F. Koca et al.

37 Meeting Organ forENT andPediatric Pulmonology: Adenoids
37. Brodsky L.Tonsil adenoid disorders. In: Gates GA, editor. Current therapy in otolaryngologyhead and neck surgery. St. Louis: Mosby; 1998. p.414–7.
38. Shin KS, Cho SH, Kim KR, Tae K, Lee SH, Park CW, Jeong JH.The role of adenoids in pediatric rhinosinusitis. Int J Pediatr Otorhinolaryngol. 2008;72(11):1643–50.
39. Niu X, Wu ZH, Xiao XY, Chen X.The relationship between adenoid hypertrophy and gastroesophageal reux disease: a meta-analysis. Medicine (Baltimore). 2018;97(41):e12540.
40. American Academy of Pediatrics; Subcommittee on Management of Sinusitis and Committee
on Quality Improvement. Clinical practice guideline: management of sinusitis. Pediatrics.
2001;108(3):798–808.
41. Rosenfeld RM. Pilot study of outcomes in pediatric rhinosinusitis. Arch Otolaryngol Head
Neck Surg. 1995;121(7):729–36.
42. Chong VF, Ong CK.Nasopharyngeal carcinoma. Eur J Radiol. 2008;66(3):437–47.
43. Mukherji SK, Castillo M.Normal cross-sectional anatomy of the nasopharynx, oropharynx,
and oral cavity. Neuroimaging Clin N Am. 1998;8(1):211–8.
44. Mankowski NL, Bordoni B.Anatomy, head and neck, nasopharynx. In: StatPearls [Internet].
Treasure Island: StatPearls Publishing; 2021.
45. Bylander-Groth A, Stenström C.Eustachian tube function and otitis media in children. Ear
Nose Throat J. 1998;77:762–4, 766, 768–769.
46. Bluestone CD.Eustachian tube function: physiology, pathophysiology, and role of allergy in
pathogenesis of otitis media. J Allergy Clin Immunol. 1983;72(3):242–51.
47. Casselbrant ML, Mandel EM, Marchisio P. Chapter 16. Acute otitis media and middle-ear
effusions. In: Wackym PA, Snow JB, editors. Ballenger’s otorhinolaryngology head and neck
surgery. 18th ed. Shelton: People’s Medical Publishing House; 2016.
48. Fokkens WJ, Lund VJ, Mullol J, etal. The European position paper on rhinosinusitis and nasal
polyps 2012. Rhinology. 2012;23:1–298.
49. Baroody FM.Chapter 196. Pediatric chronic rhinosinusitis. In: Flint PW, Haughey BH, Lund
V, et al., editors. Cummings otolaryngology: head & neck surgery. 6th ed. Philadelphia:
Elsevier Saunders; 2015.
50. Rachelefsky GS, Goldberg M, Katz RM, et al. Sinus disease in children with respiratory
allergy. J Allergy Clin Immunol. 1978;61:310–4.
51. Rachelefsky GS, Shapiro GG. Diseases of paranasal sinuses in children. In: Bierman W,
Pearlman D, editors. Management of upper respiratory tract disease. Philadelphia: WB
Saunders; 1980.
52. Tatli MM, San I, Karaoglanoglu M.Paranasal sinus computed tomographic ndings of children with chronic cough. Int J Pediatr Otorhinolaryngol. 2001;60(3):213–7.
53. Elwany S, El-Dine AN, El-Medany A, etal. Relationship between bacteriology of the adenoid
core and middle meatus in children with sinusitis. J Laryngol Otol. 2011;125(3):279–81.
54. Shin KS, Cho SH, Kim KR, etal. The role of adenoids in pediatric rhinosinusitis. Int J Pediatr
Otorhinolaryngol. 2008;72:1643–50.
55. Bercin AS, Ural A, Kutluhan A, etal. Relationship between sinusitis and adenoid size in pediatric age group. Ann Otol Rhinol Laryngol. 2007;116(7):550–3.
56. Ramadan HH, Tiu J.Failures of adenoidectomy for chronic rhinosinusitis in children: for
whom and when do they fail? Laryngoscope. 2007;117(60):1080–3.
57. Ramadan HH, Cost JL. Outcome of adenoidectomy versus adenoidectomy with maxillary
sinus wash for chronic rhinosinusitis in children. Laryngoscope. 2008;118(5):871–3.
58. Glasier CM, Ascher DP, Williams KD.Incidental paranasal sinus abnormalities on CT of children: clinical correlation. Am J Neuroradiol. 1986;7(5):861–4.
59. Diament MJ, Senac MO Jr, Gilsanz V, etal. Prevalence of incidental paranasal sinuses opacication in pediatric patients: a CT study. J Comput Assist Tomogr. 1987;11(3):426–31.
60. Hill M, Bhattacharyya N, Hall TR, etal. Incidental paranasal sinus imaging abnormalities and
the normal Lund score in children. Otolaryngol Head Neck Surg. 2004;130:171–5.
61. Bhattacharyya N, Jones DT, Hill M, etal. The diagnostic accuracy of computed tomography in
pediatric chronic rhinosinusitis. Arch Otolaryngol Head Neck Surg. 2004;130:1029–32.
489

490
62. Marseglia GL, Caimmi D, Pagella F, Matti E, Labo E, Licari A.Adenoids during childhood:
the facts. Int J Immunopathol Pharmacol. 2011;24(4 Suppl):1–5.
63. Avanzini AM, Castellazzi AM, Marconi M, Valsecchi C, Marseglia A, Ciprandi G.Children
with recurrent otitis show defective IFN-gamma producing cells in adenoids. Pediatr Allergy
Immunol. 2008;19:523–6.
64. Wang B, Tang X, Xu J, Yao H.Differential expression of immunoglobulin A in the adenoids of children with and without exudative otitis media. Int J Pediatr Otorhinolaryngol.
2012;76:728–30.
65. Ricci A, Avanzini MA, Scaramuzza C, Castellazzi AM, Marconi M, Marseglia GL.Toll-like
receptor 2-positive and Toll-like receptor 4-positive cells in adenoids of children exposed to
passive smoking. J Allergy Clin Immunol. 2005;115:631–2.
66. Granath A, Uddman R, Cardell LO.Increased TLR7 expression in the adenoids among children with otitis media with effusion. Acta Otolaryngol. 2010;130:57–61.
67. De Amici M, Ciprandi G, Marseglia A, Licari A, Matti E, Caputo M.Adenoid hypetrophy:
denition of some risk factors. J Biol Regul Homeost Agents. 2012;26(1 Suppl):S1–7.
68. Ameli F, Brocchetti F, Tosca MA, Signori A, Ciprandi G.Adenoidal hypertrophy and allergic
rhinitis: is there an inverse relationship? Am J Rhinol Allergy. 2013;27:e5–10.
69. Marseglia GL, Avanzini MA, Caimmi S, Caimmi D, Marseglia A, Valsecchi C, etal. Passive
exposure to smoke results in defective IFN-gamma production by adenoids in children with
recurrent respiratory infections. J Interferon Cytokine Res. 2009;29:427–32.
70. Elwany S, Ibrahim AA, Mandour Z, Talaat I.Effect of passive smoking on the ultrastructure of
the nasal mucosa in children. Laryngoscope. 2012;122:965–9.
71. Aycicek A, Dilek H, Sargın R, Sahin O, Kenar F, Derekoy SO.Heat shock protein 70 and
inducible nitric oxide synthase expression in adenoid tissue of children exposed to passive
smoke. Türkiye Klinikleri J Med Sci. 2009;29:1528–34.
72. Di Martino E, Mlynski G, Mlynski B. Effect of adenoid hyperplasia on nasal airow.
Laryngorhinootologie. 1998;77(5):272–4.
73. Niedzielska G, Kotowski M, Niedzielski A.Assessment of pulmonary function and nasal ow
in children with adenoid hypertrophy. Int J Pediatr Otorhinolaryngol. 2008;72(3):333–5.
74. Modrzynski M, Zawisza E.An analysis of the incidence of adenoid hypertrophy in allergic
children. Int J Pediatr Otorhinolaryngol. 2007;71:713–9.
75. Kavukcu S, Coskun S, Cevik N, Kuscu B, Akkoclu A.The importance of pulmonary function
tests in adenotonsillectomy indications. Indian J Pediatr. 1993;60:249–55.
76. Aykan M, Aydın S, Öktem S, Demir MG, Tutar E.Effect of adenoid hypertrophy and pulmonary
function tests in children with mild asthma. Kulak Burun Bogaz Ihtis Derg. 2016;26(5):253–7.
77. Maurizi M, Paludetti G, Todisco T, Dottorini M, Grassi V.Pulmonary function studies in adenoid hypertrophy. Int J Pediatr Otorhinolaryngol. 1980;2:243–50.
Ç. F. Koca et al.

Meeting Organ forENT andPediatric
Pulmonology: Tonsils
DuyguDemirbaşKeskin, AyşeSeçilKayalıDinç,
andAndrewA.Winkler
38.1 Introduction
Tonsils are lymphoid tissue structures positioned close to the entrance of the digestive and respiratory tracts and play a key role in our immune system. Together, the
lingual tonsil at the posterior third of the tongue, the paired palatine tonsils laterally,
the nasopharyngeal tonsil (adenoid) posterosuperior, and the paired tubal tonsils at
the pharyngeal openings of the Eustachian tubes form a ring of lymphoid tissue
called Waldeyer’s ring [1–5]. They are crucial in preventing infection and act as the
rst defense against ingested or inhaled pathogens [2].
38.2 Anatomy
38
38.2.1 Palatine Tonsils (Faucial Tonsils)
The palatine tonsils are the most signicant lymphoid tissue aggregation in
Waldeyer’s ring, rst described by German anatomist Heinrich Wilhelm Gottfried
von Waldeyer-Hartz [2, 5] and generally referred to as “the tonsils.”
D. D. Keskin (*)
Department of Otorhynolaryngology, Acıbadem Zekeriyakoy Medical Center, Department of
Medical education PhD.c., Acıbadem MAA University Institute of Health Sciences, İstanbul,
Turkey
A. S. K. Dinç
Department of Otorhynolaryngology, Ankara Bilkent City Hospital, Ankara, Turkey
A. A. Winkler
Department of Otolaryngology, University of Colorado School of Medicine,
Aurora, CO, USA
© The Author(s), under exclusive license to Springer Nature
Switzerland AG 2024
H. Yüksel et al. (eds.), Pediatric Airway Diseases, Comprehensive ENT,
https://doi.org/10.1007/978-3-031-74853-0_38
491
Соседние файлы в папке Библиотека им академика М.И. Перельмана
